29
Oversold
Moving averages
SMA 200$18.57-28.22%
Company profile
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapies, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. The company is headquartered in Cambridge, Massachusetts.
SectorHealthcare
IndustryBiotechnology
Market cap$1.79B
P/E ratio834.0
EPS$0.02
Beta0.454
Dividend yield0.00%
52-week high$24.68
52-week low$14.68
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 32
VRTX
Vertex Pharmaceuticals Inc
RSI 43
CRSP
CRISPR Therapeutics AG
RSI 27
IOVA
Iovance Biotherapeutics Inc
RSI 31
NVAX
Novavax Inc
RSI 33
NTLA
Intellia Therapeutics Inc
RSI 37
MRVI
Maravai LifeSciences Holdings Inc - Class A
RSI 48
GPCR
Structure Therapeutics Inc
RSI 25
AUPH
Aurinia Pharmaceuticals Inc
RSI 32
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 34
RSI alerts for SRPT
An email when SRPT closes below RSI 30 or above 70. Nothing else.
Data last updated 13 November 2026 at 2:11 AM EST